Capital Management, L.p. Ra serves as Executive at Phathom Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Capital Management, L.p. Ra has executed 101 insider transactions totaling $453.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 27, 2020 involved purchasing 30,000 shares valued at $738.0K.
Capital Management, L.p. Ra currently holds 8,300 shares of Phathom Pharmaceuticals, Inc. (PHAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Management, L.p. Ra has been a net buyer of PHAT stock. They have purchased $431.9M and sold $21.6M worth of shares.
Capital Management, L.p. Ra's most recent insider trade was on Mar 27, 2020, when they purchased 30,000 shares at $24.60 per share.
Get notified when new Form 4 filings are submitted